1Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in in- traocular pressure are an independent risk factor in patients with glauco- ma[ J 1. J Glaucoma,2010 ;9 ( 3 ) : 134-42.
2Wax MB, Camras CB, Fiscella RG, et al. Emerging perspectives in glau- coma: optimiziog 24-hour control of intraocular pressure [ J 1. Am J Oph- thalmo1,2009 ; 133 ( 3 ) : 134-42.
3Hedman K, AlmA. A pooled-data analysis of three randomized, double- masked, six-month clinical studies comparing the intraocular pressure re- ducing effect of latanoprost and timold J 1. Eur J Ophthalmo1,2010 ; 10 ( 1 ) :95-104.
4Parrish RK, Palmberg P, Sheu WP, et al. A comparison of latanoprost, bi- matoprost,and travoprost in patients with elevated intraocular pressure:a 12 -week, randomized, masked-evaluatormulticenter study [ J 1. Am J Oph- thalmo1,2008 ; 135 (5) :688-703.
6Orzalesi N, Rossetti L, Bottoli A, et al. Comparison of the effects of latano- prost, travoprost, and bimatoprost on cricadian itraocular pressure in pa- tients with glaucoma or ocular hypertension [ J . Ophthaloology,2006 ; 113 ( 3 ) :239-46.
2Parrish RK,Palmberg P,Sheu WP,et al.A comparison of latanoprost,bimatoprost,and travoprost in patients with elevated intraocular pressure:a 12-week,randomized,masked-evaluator multicenter study[J].Am J Ophthalmol,2003,135(5):688-703.
3Hedman K,Alm A.A pooled-data analysis of three randomized,double-masked,six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol[J].Fur J Ophthalmol,2000,10(1):95-104.
4Netland PA,Landry T,Sullivan EK,et al.Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension[J].Am J Ophthalmol,2001,132(4):472-484.
5Higginbotham EJ,Schuman JS,Goldberg I,et al.One-year,randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension[J].Arch Ophthalmol,2002,120(10):1286-1293.
6Noecker RJ,Dirks MS,Choplin NT.A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with oculsu hypertension or glaucoma[J].Am J Ophthalmol,2003,135 (1):55-63.
7Cantor LB,WuDunn D,Cortes A,et al.Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension[J].Surv Ophthalmol,2004,49 (Suppl 1):S12-S18.
